Equities

Zhejiang CONBA Pharmaceutical Co Ltd

600572:SHH

Zhejiang CONBA Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)4.04
  • Today's Change-0.01 / -0.25%
  • Shares traded15.22m
  • 1 Year change-23.05%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,3852,4332,454
Total Receivables, Net1,8311,7291,802
Total Inventory1,3331,1281,044
Prepaid expenses417146
Other current assets, total18535120
Total current assets5,7755,3955,466
Property, plant & equipment, net3,0583,2293,280
Goodwill, net185185185
Intangibles, net370391381
Long term investments1,7271,6331,885
Note receivable - long term------
Other long term assets------
Total assets11,23810,93011,274
LIABILITIES
Accounts payable700594508
Accrued expenses252283216
Notes payable/short-term debt9697521,465
Current portion long-term debt/capital leases82145134
Other current liabilities, total1,1691,016844
Total current liabilities3,1732,7893,168
Total long term debt30633413
Total debt1,3571,2311,613
Deferred income tax268327310
Minority interest309410434
Other liabilities, total142155148
Total liabilities4,1974,0164,073
SHAREHOLDERS EQUITY
Common stock2,5702,5702,570
Additional paid-in capital210150360
Retained earnings (accumulated deficit)4,2614,1944,271
Treasury stock - common------
Unrealized gain (loss)0.040.05--
Other equity, total(0.04)0.050.27
Total equity7,0416,9147,201
Total liabilities & shareholders' equity11,23810,93011,274
Total common shares outstanding2,5702,5702,570
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.